FCGR2A and cancer: mRNA levels of FcγR family were remarkably upregulated in four cancer types, namely, brain and CNS, breast, head and neck colorectal and kidney, while mRNA levels of FcγRs were downregulated in leukemia and lung cancer (Figure 1A).